Pyxis Oncology, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
DEEP TRACK CAPITAL, LP | 11/14/2024 | 4.18 M | $15.36 M | 0.00% | 6.89% |
LAURION CAPITAL MANAGEMENT LP | 11/14/2024 | 3.63 M | $13.31 M | -6.09% | 5.97% |
BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 2.96 M | $10.88 M | 100.00% | 4.88% |
VANGUARD GROUP INC | 11/13/2024 | 2.43 M | $8.93 M | 18.08% | 4.01% |
MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 1.91 M | $7.00 M | 42.64% | 3.14% |
BLUE OWL CAPITAL HOLDINGS LP | 11/14/2024 | 1.13 M | $4.13 M | 7.65% | 1.85% |
GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.08 M | $3.98 M | 5.55% | 1.79% |
IKARIAN CAPITAL, LLC | 11/14/2024 | 957,408 | $3.51 M | -42.41% | 1.58% |
STATE STREET CORP | 11/14/2024 | 951,251 | $3.49 M | 28.04% | 1.57% |
ABRDN PLC | 10/25/2024 | 913,045 | $3.35 M | 28.91% | 1.50% |
STEMPOINT CAPITAL LP | 11/13/2024 | 850,210 | $3.12 M | -29.31% | 1.40% |
PERCEPTIVE ADVISORS LLC | 11/14/2024 | 508,462 | $1.87 M | 100.00% | 0.84% |
683 CAPITAL MANAGEMENT, LLC | 11/14/2024 | 414,656 | $1.52 M | 100.00% | 0.68% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 11/14/2024 | 382,840 | $1.41 M | 100.00% | 0.63% |
HHLR ADVISORS, LTD. | 11/14/2024 | 382,606 | $1.40 M | 0.00% | 0.63% |
IKARIAN CAPITAL, LLC | 11/14/2024 | 358,600 | $1.32 M | 9,900.00% | 0.59% |
DECHENG CAPITAL LLC | 11/15/2024 | 326,810 | $1.20 M | 0.00% | 0.54% |
BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2024 | 283,616 | $1.04 M | -42.41% | 0.47% |
CITADEL ADVISORS LLC | 11/14/2024 | 275,951 | $1.01 M | 100.00% | 0.45% |
BANK OF NEW YORK MELLON CORP | 11/12/2024 | 272,769 | $1.00 M | -12.47% | 0.45% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 265,295 | $973,633 | 7.63% | 0.44% |
BALYASNY ASSET MANAGEMENT L.P. | 11/14/2024 | 224,957 | $825,592 | -91.22% | 0.37% |
PALO ALTO INVESTORS LP | 11/14/2024 | 170,000 | $623,900 | 100.00% | 0.28% |
RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 160,336 | $588,433 | 65.40% | 0.26% |
AMERICAN CENTURY COMPANIES INC | 11/12/2024 | 159,439 | $585,141 | 173.71% | 0.26% |
MORGAN STANLEY | 11/14/2024 | 153,248 | $562,420 | 85.51% | 0.25% |
NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 149,024 | $546,918 | 0.00% | 0.25% |
GOLDMAN SACHS GROUP INC | 11/14/2024 | 139,132 | $510,614 | 18.66% | 0.23% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 129,761 | $476,223 | 0.00% | 0.21% |
SCHULHOFF & CO INC | 11/06/2024 | 122,000 | $447,740 | 190.48% | 0.20% |
PIER 88 INVESTMENT PARTNERS LLC | 11/06/2024 | 121,610 | $446,309 | 6.96% | 0.20% |
MARSHALL WACE, LLP | 11/14/2024 | 116,359 | $427,037 | 1,063.59% | 0.19% |
NEWEDGE WEALTH, LLC | 11/12/2024 | 116,006 | $425,742 | 100.00% | 0.19% |
BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2024 | 99,100 | $363,697 | 0.00% | 0.16% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 85,818 | $314,952 | -25.82% | 0.14% |
XTX TOPCO LTD | 11/14/2024 | 84,771 | $311,110 | 133.59% | 0.14% |
DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 81,946 | $300,741 | 0.01% | 0.14% |
LMR PARTNERS LLP | 11/07/2024 | 80,000 | $293,600 | 100.00% | 0.13% |
QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 72,887 | $267,495 | 7.17% | 0.12% |
YU FAN | 11/14/2024 | 69,303 | $254,342 | 0.00% | 0.11% |
RHUMBLINE ADVISERS | 11/12/2024 | 64,428 | $236,443 | -1.32% | 0.11% |
BARCLAYS PLC | 11/19/2024 | 64,089 | $235,000 | 274.96% | 0.11% |
CABLE CAR CAPITAL LLC | 11/14/2024 | 61,606 | $226,094 | 0.00% | 0.10% |
JANE STREET GROUP, LLC | 11/15/2024 | 49,558 | $181,878 | 40.75% | 0.08% |
UNIVERSITY OF CHICAGO | 10/16/2024 | 48,731 | $178,843 | 0.00% | 0.08% |
MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 47,600 | $174,692 | 100.00% | 0.08% |
BANK OF AMERICA CORP /DE/ | 11/14/2024 | 44,683 | $163,986 | -0.22% | 0.07% |
ROYAL BANK OF CANADA | 11/14/2024 | 35,326 | $130,000 | 17.00% | 0.06% |
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | 11/15/2024 | 29,100 | $106,797 | 100.00% | 0.05% |
SIMPLEX TRADING, LLC | 11/08/2024 | 28,470 | $104,000 | -30.15% | 0.05% |
Pyxis Oncology, Inc.institutional Ownership - FAQ's
During the previous two years, 103 institutional investors and hedge funds held shares of Pyxis Oncology, Inc.. The most heavily invested institutionals were:
Deep Track Capital, LP: 4.18 M
Laurion Capital Management LP: 3.63 M
BlackRock Funding, Inc. /DE: 2.96 M
VANGUARD GROUP INC: 2.43 M
MILLENNIUM MANAGEMENT LLC: 1.91 M
Blue Owl Capital Holdings LP: 1.13 M
45.93% of Pyxis Oncology, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 31.12 M shares in the last 24 months. This purchase volume represents approximately $49.48 M in transactions.